130 related articles for article (PubMed ID: 16271359)
1. Modulation of ATP-mediated contractions of the rat vas deferens through presynaptic cannabinoid receptors.
Tambaro S; Mongeau R; Dessi C; Pani L; Ruiu S
Eur J Pharmacol; 2005 Nov; 525(1-3):150-3. PubMed ID: 16271359
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
Barun S; Vural IM; Dileköz E; Ercan ZS; Sarioglu Y
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):702-7. PubMed ID: 16173925
[TBL] [Abstract][Full Text] [Related]
3. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
Aboud R; Shafii M; Docherty JR
Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
Ruiu S; Pinna GA; Marchese G; Mussinu JM; Saba P; Tambaro S; Casti P; Vargiu R; Pani L
J Pharmacol Exp Ther; 2003 Jul; 306(1):363-70. PubMed ID: 12663689
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
Pertwee RG; Griffin G; Lainton JA; Huffman JW
Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
Liu Q; Bhat M; Bowen WD; Cheng J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
Bültmann R; Kurz AK; Starke K
Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
[TBL] [Abstract][Full Text] [Related]
9. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC
Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536
[TBL] [Abstract][Full Text] [Related]
10. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways.
Yoshihara S; Morimoto H; Yamada Y; Abe T; Arisaka O
Am J Respir Crit Care Med; 2004 Nov; 170(9):941-6. PubMed ID: 15306537
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.
Christopoulos A; Coles P; Lay L; Lew MJ; Angus JA
Br J Pharmacol; 2001 Mar; 132(6):1281-91. PubMed ID: 11250879
[TBL] [Abstract][Full Text] [Related]
14. Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
Kushmerick C; Price GD; Taschenberger H; Puente N; Renden R; Wadiche JI; Duvoisin RM; Grandes P; von Gersdorff H
J Neurosci; 2004 Jun; 24(26):5955-65. PubMed ID: 15229243
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
16. Effect of in vivo and in vitro ethanol on adrenergic and purinergic responses of the bisected rat vas deferens to low and high frequency pulses.
Boselli C; Govoni S
J Auton Pharmacol; 2001 Aug; 21(4):171-9. PubMed ID: 11952872
[TBL] [Abstract][Full Text] [Related]
17. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K
Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
[TBL] [Abstract][Full Text] [Related]
18. Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release.
Schlicker E; Redmer A; Werner A; Kathmann M
Br J Pharmacol; 2003 Sep; 140(2):323-8. PubMed ID: 12970076
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
[TBL] [Abstract][Full Text] [Related]
20. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors.
Major TC; Weishaar RE; Taylor DG
Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
